ARIXTRA
Live / Registered — Registered and renewed (as of 17 Apr 2023)
What this means for you
Registered since 10 Jun 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Jun 2023).
Record
- Serial number
- 76251409
- Registration number
- 2725323
- Mark type
- Design + words
- Filed
- 04 May 2001
- Published for opposition
- 09 Oct 2001
- Registered
- 10 Jun 2003
- Next maintenance due
- 10 Jun 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and for the treatment of cardiovascular diseases or disorders
- Class 010 — Medical apparatus: Syringes for medical use
Owner
- MYLAN INSTITUTIONAL INC., ROCKFORD, IL, US
- Glaxo Group Limited, Brentford, Middlesex, GB
- Sanofi-Synthelabo, 75013 Paris, FR
- Sanofi-Synthelabo, 75013 Paris, FR
- Sanofi-Synthelabo, 75013 Paris, FR
Prior registrations
Prosecution history
- 17 Apr 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 17 Apr 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Apr 2023 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 17 Apr 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 02 Mar 2023 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 04 Jan 2023 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 04 Jan 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Jun 2022 — TEAS SECTION 8 & 9 RECEIVED
- 10 Jun 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Dec 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Nov 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Nov 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Nov 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jul 2014 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Mar 2013 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED